Tekton is expanding to Houston, TX, with the addition of Lawrence D. Ginsberg, MD. Dr. Ginsberg will lead adult and pediatric psychiatry studies as a Principal Investigator from his clinic, Red Oak Psychiatry Associates. This marks Tekton’s first research location in Houston. Dr. Ginsberg has practiced psychiatry since 1985 and has served as president and … Read more
Andrew H. Martin, MD, psychiatrist and founder of Texas Family Psychiatry, will expand Tekton’s psychiatry research capabilities in San Antonio. Tekton is pleased to welcome Andrew H. Martin, MD, as a Principal Investigator at its San Antonio dedicated research center. Dr. Martin is a psychiatrist with more than 20 years of clinical experience treating children, … Read more
As CNS capabilities expand, Tekton adds seasoned leadership to accelerate growth and execution AUSTIN, TX – May 6, 2026 — Tekton Research, a leading multi-site clinical trial organization with 25 research sites across North America, today announced the appointment of Amit Vijapura, MD as a Central Nervous System (CNS) Key Opinion Leader (KOL), further strengthening … Read more
CNS (central nervous system) trials are some of the most complex–and most meaningful–studies in clinical research today. A recent Society for Clinical Research Sites (SCRS) SCRS Talks episode featuring Tekton’s Jeffrey Zucker and Brandon Lenfest explored the realities of conducting CNS trials—from patient identification to caregiver impact. In this article, we revisit the most compelling moments from that discussion and … Read more
February is Black History Month, a time to celebrate the achievements, resilience, and lasting impact of Black leaders across every field, including medicine and clinical research. At Tekton Research, we take this opportunity to reflect on the pioneers whose contributions have shaped the medical world and the lessons their stories teach us about ethics, trust, … Read more